New technology to tackle treatment-resistant cancers
February 2, 2012 by admin · Leave a Comment
Free-flowing cancer cells have been mapped with unprecedented accuracy in the bloodstream of patients with prostate, breast and pancreatic cancer, using a brand new approach, in an attempt to assess and control the disease as it spreads in real time through the body, and solve the problem of predicting response and resistance to therapies.
Proton therapy effective prostate cancer treatment
January 4, 2012 by admin · Leave a Comment
Proton therapy, a type of external beam radiation therapy, is a safe and effective treatment for prostate cancer, according to two new studies published in the January issue of the International Journal of Radiation OncologyBiologyPhysics (Red Journal), the American Society for Radiation Oncology’s (ASTRO) official scientific journal.
Researchers discover Achilles’ heel in lethal form of prostate cancer
November 16, 2011 by admin · Leave a Comment
An international team of researchers led by clinicians at Weill Cornell Medical College have discovered a genetic Achilles’ heel in an aggressive type of prostate cancer — a vulnerability they say can be attacked by a targeted drug that is already in clinical trials to treat other types of cancers.
Starving prostate cancer
October 31, 2011 by admin · Leave a Comment
Each year about 3300 Australian men die of prostate cancer. It’s Australia’s second worst cancer killer for men, matching the impact of breast cancer on women.
Current therapies for prostate cancer include surgical removal of the prostate, radiation, freezing the tumour or cutting off the supply of the hormone testosteronebut there are often side-effects including incontinence and impotence.
New, unique clinical study designed for men with pain caused by prostate cancer
September 26, 2011 by admin · Leave a Comment
With National Prostate Cancer Awareness Month taking place throughout September, it is important to focus not only on screening and prevention, but also the very real experience of those men living with advanced forms of the disease. For these men, quality of life can be a significant issue. For instance, an advanced form of the disease called metastatic castrate resistant prostate cancer (mCRPC), often spreads to the bone causing debilitating pain. While new treatments are allowing men with mCRPC to live longer lives, some experts believe that the goal of treatment should be not only to extend survival, but also to improve quality of life. Cancer-related pain can cause men to lose the ability to perform even simple daily tasks such as standing up and walking around. Currently, narcotics, like morphine, are used to provide some relief, but side effects of these medications can be difficult to tolerate. For example, many people have difficulty with side effects such as confusion, disorientation, forgetfulness or severe constipation. Even with narcotics, some men continue to experience pain. To help explore a potential new option, The Prostate Cancer SATURN Clinical Trial is actively enlisting men with MCRPc from across the country to evaluate whether an investigational treatment, added to chemotherapy, can improve quality of life by reducing cancer pain. Men living with prostate cancer-related pain, or their loved ones, are encouraged to learn more about this clinical trial by calling 1-977-888-3762 or visiting www.prostatepainstudy.com.
First Phase III trial of an alpha-pharmaceutical shows improved survival in patients with bone metastases and advanced prostate cancer
September 22, 2011 by admin · Leave a Comment
Stockholm, Sweden: Until recently, options for patients with bone metastases from advanced prostate cancer have been very limited. But now the first Phase III study of an alpha-pharmaceutical in these patients has shown that it can prolong survival significantly, according to research reported today (Saturday) at the 2011 European Multidisciplinary Cancer Congress [1].
Queen’s pioneers prostate cancer breakthrough
September 18, 2011 by admin · Leave a Comment
Scientists at Queen’s University have pioneered a new combination treatment for prostate cancer. The treatment, which has been successful in phase one of trials, will now be tested for efficacy in a second phase.
UCSB develops breakthrough technology in identification of prostate cancer cells
September 18, 2011 by admin · Leave a Comment
A team of researchers at UC Santa Barbara has developed a breakthrough technology that can be used to discriminate cancerous prostate cells in bodily fluids from those that are healthy. The findings are published this week in the Proceedings of the National Academy of Sciences.
New prostate cancer screening test shows promise for diagnosis
August 14, 2011 by admin · Leave a Comment
Novel assay found to be more accurate than traditional screening
CLEVELAND - A new prostate screening test developed by AnalizaDx, Inc., a Cleveland-based biotech company, and studied by researchers at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center along with colleagues at the Cleveland Clinic, the Veterans Administration Boston Healthcare and the National Cancer Institute, may prove to be a promising new tool in the diagnosis of prostate cancer. The study which will be published in the September issue of Urology found that this new screening test, the PSA/SIA assay, may be more sensitive in detecting prostate cancer than traditional screening methods.
New treatment option for advanced prostate cancer
August 11, 2011 by admin · Leave a Comment
A successful interdisciplinary project is underway between two research groups, in which senior researcher Rebecka Hellsten and Professor Anders Bjartell at the Faculty of Medicine’s division for Urological Cancer Research, Skåne University Hospital in Malmö, and Professor Olov Sterner and Assistant Professor Martin Johansson at the Lund University division of Organic Chemistry recently published their latest research findings in the scientific online journal PLoS ONE.
